









Markets
/
Stocks
/
nasdaq-ocs
/

Oculis Holding AG

OCS

View Detailed Chart

17.700USD

+0.060+0.34%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

983.42MMarket Cap

LossP/E TTM



Oculis Holding AG

17.700

+0.060+0.34%

Overview Company Financials

Financials

Intraday

30m

Today

+0.34%

5 Days

-0.06%

1 Month

-6.84%

6 Months

-22.57%

Year to Date

+4.12%

1 Year

+55.26%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

STRONG BUY

Current Rating

36.286

Target Price

105.00%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Oculis Holding AG

OCS

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(5)

Buy(0)

Indicators

Sell(2)

Neutral(5)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.028

Neutral

RSI(14)

41.739

Neutral

STOCH(KDJ)(9,3,3)

35.564

Neutral

ATR(14)

0.568

High Vlolatility

CCI(14)

-51.160

Neutral

Williams %R

64.444

Sell

TRIX(12,20)

-0.307

Sell

StochRSI(14)

18.600

Neutral

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

17.814

Sell

MA10

17.765

Sell

MA20

17.975

Sell

MA50

18.810

Sell

MA100

18.423

Sell

MA200

18.340

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Ticker SymbolOCS

CompanyOculis Holding AG

CEODr. Riad Sherif, M.D.

Websitehttps://oculis.com/